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Abstract 
  Fructose is a simple sugar present in honey and fruit, but can also exist as a polymer 
(fructans) in pasture grasses.  Mammals are unable to metabolize fructans, but certain gram 
positive bacteria contain fructanases and can convert fructans to fructose in the gut.  Recent 
studies suggest that fructose generated from bacteria, or directly obtained from the diet, can 
induce both increased intestinal permeability and features of metabolic syndrome, especially the 
development of insulin resistance.  The development of insulin resistance is driven in part by the 
metabolism of fructose by fructokinase C in the liver, which results in oxidative stress in the 
hepatocyte.  Similarly, the metabolism of fructose in the small bowel by intestinal fructokinase 
may lead to increased intestinal permeability and endotoxemia.  While speculative, these 
observations raise the possibility that the mechanism by which fructans induce laminitis could 
involve intestinal and hepatic fructokinase.  Further studies are indicated to determine the role of 
fructanases, fructose and fructokinase in equine metabolic syndrome and laminitis. 
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  Fructose is a monosaccharide present in fruit and honey, but is also a component of sugar 
(sucrose) and high fructose corn syrup (HFCS).  Fructose can also be generated  by the 
breakdown of fructans by bacteria in the gut.  Recent studies suggest that the unique metabolism 
of fructose by fructokinase C can lead to increased intestinal permeability and the development 
of insulin resistance and features of metabolic syndrome.  The potential involvement of fructose 
and fructokinase as mediator systems involved in equine related diseases are briefly discussed. 
 
Fructose and Fructokinase as Mediators of Insulin Resistance and Metabolic 
Syndrome 
  Fructose is unique among foods in its remarkable ability to induce metabolic syndrome in 
animals.  The administration of fructose to laboratory rats, for example, can induce insulin 
resistance, elevated blood pressure, increased serum triglycerides, low HDL cholesterol, fatty 
liver (hepatic steatosis), and increased visceral fat stores [1].  Fructose administration also 
induces leptin resistance in rats, resulting in increased energy intake and weight gain [2].  While 
the intake of fructose (or sucrose, which contains fructose) can lead to increased energy intake, 
the ability of fructose to induce insulin resistance and other features of metabolic syndrome does 
not require excessive energy intake.  For example, we have reported that when rats are fed the 
same total number of calories, that the rats fed a high fructose (or sucrose) diet develop features 
of metabolic syndrome whereas glucose (or starch) fed animals do not [3-5].  Laboratory rats 
will even develop fatty liver and insulin resistance when placed on dietary restriction provided 
that the diet is enriched in sucrose [6] .  
  There is also evidence that fructose, especially when present in added sugars such as 
sucrose or HFCS, may have a role in metabolic syndrome in humans.  The ingestion of sugary 
soft drinks is strongly associated with the development of insulin resistance and obesity [7]. 
Experimental studies also show a unique ability of fructose as compared to glucose to induce 
insulin resistance and visceral fat accumulation in humans [8].  In one study, the administration 
of fructose (200 g/d) resulted in the de novo development of metabolic syndrome in 25 percent 4 
 
of healthy men in only two weeks [9]. This has led to interest into the role of fructose in the 
epidemic of obesity and diabetes [10]. 
  The observation that fructose induces features of metabolic syndrome independent of 
energy intake suggests there is something unique about the metabolism of fructose that may be 
responsible for its metabolic effects.  Fructose is distinct from glucose only in its initial steps of 
metabolism.  Fructose is taken up by the fructose-specific transporter, Glut5, in the intestinal 
epithelium, and then is transported to the liver. Here much of the fructose is metabolized by the 
enzyme, fructokinase C (also known as ketohexokinase C, or KHK-C) to generate fructose-1-
phosphate (Figure 1). Unlike glucokinase, which has a negative feedback system to prevent 
excessive phosphorylation of glucose, KHK-C will rapidly phosphorylate the fructose, resulting 
in intracellular phosphate and ATP depletion [11].  Hepatic ATP depletion occurs in response to 
relatively small doses of fructose in both laboratory animals and humans [12-13]. 
  There is increasing evidence that the intracellular ATP depletion may have a role in 
inducing the metabolic phenotype.  Evidence for this came from studies investigating the role of 
KHK-C and a different KHK isoform, KHK-A, in laboratory mice. Unlike KHK-C, the 
metabolism of fructose by KHK-A is slow with only minimal ATP consumption.  Interestingly, 
the obesity, fatty liver and insulin resistance that occurs in fructose-fed mice is prevented in mice 
lacking both KHK-C and KHK-A, but was exacerbated in KHK-A knockout despite similar 
overall energy intake [14]. The mechanism appeared to be due to the fact that a lack of KHK-A 
resulted in more delivery of fructose to the liver where it was metabolized by KHK-C.  These 
studies suggest a key role for hepatic KHK-C in the induction of insulin resistance. 
 
Fructose, Fructokinase, and Intestinal Permeability 
As mentioned, the metabolism of fructose by KHK-C  results in transient intracellular 
phosphate and ATP depletion. This process is not benign, and leads to transient interruption of 
protein synthesis [15].   The intracellular phosphate depletion also stimulates AMP deaminase, 
which leads to the stepwise degradation of adenine nucleotides to generate uric acid inside the 
cell [11, 16-18].   In kidney epithelial cells we have found that fructose stimulates the production 5 
 
of oxidants and monocye chemoattractant protein-1 (MCP-1)  via a KHK-dependent pathway 
[18].  We also have found that fructose can increase oxidative stress in hepatocytes (HepG2 
cells) and this can be prevented in cells in which KHK has been silenced (Lanaspa MA, 
unpublished).   
The major sites of KHK-C expression in laboratory animals and humans is the liver, 
small intestine, and kidney [19].   We have found that KHK-C is expressed in both the small 
bowel and cecum of the mouse, with the highest expression in the duodenum and jejunum 
(Figure 2).  This raises the possibility that the metabolism of fructose in the intestinal wall might 
lead to local inflammation and increased intestinal permeability. Indeed, the administration of 
fructose to rats has been reported to cause transient endotoxemia in the rat, documenting an 
increase in intestinal permeability [20].   We have also found that fructose reduces claudin 4 
expression in cultured intestinal epithelial (Caco-2) cells, consistent with alterations in tight 
junctions that would increase intestinal permeability (Lanaspa MA, unpublished).  Moreover, 
wild type mice administered fructose (15% in water) show both an increased expression in 
fructokinase mRNA in the duodenum, but also a decrease in expression of tight junction genes 
including occludin and ZO-1.  These alterations are not observed in mice in which both 
fructokinase A and C isoforms have been deleted (Figure 3).  Thus, the metabolism of fructose 
might be expected to result in intestinal wall permeability and the development of metabolic 
syndrome.  In addition, if a large amount of fructose is administered, the fructose that is not 
absorbed is rapidly broken down by gut bacteria to generate a lactic acidosis [21]. 
 
Fructans: A Storage Form of Fructose Critical for Temperate Grasses 
Plants use photosynthesis to generate carbohydrates as the primary fuels for energy.  In 
the tropics the two major carbohydrates generated are starch and sucrose. Warm season (C4) 
grasses typically produce starch which is concentrated in chloroplasts and has limited storage 
capacity since it can be rapidly saturated; hence it is stored in the leaves and is utilized relatively 
soon after production [22].   Certain C4 grasses, such as sugarcane and sorghum, produce 
sucrose [23].  In contrast, grasses living in temperate zones (cool season, C3 grasses), as well as 6 
 
perennial flowering plants, store energy as polymers of fructose (fructans) which they use a 
major nutritional source [24].    
The production of fructans begins with the generation of triose phosphate (a 3-carbon 
sugar) in the chloroplast which is transferred to the cytoplasm, converted to sucrose and moved 
to the vacuole where it is converted to fructans with the release of glucose via a series of 
enzymatic steps [25].   Two major types of fructans exist, consisting  of levans, which are 
polymers consisting of β(26)-linked  fructosyl units with branching at the 2-1 position, and 
inulins, which have β(21) linked fructosyl units with a terminal  glucose unit [26].   The 
number of polymers in any fructan molecule can vary from 3 to 200[26], with most plants having 
fructans with polymers in the range of 3 to 60 [25].  The fructans are then transported via the 
plant circulation where they concentrate in vacuoles in the stems , tubers, and roots [25].   Large 
amounts of fructans can be generated and stored, accounting for up to 70% of the dry weight of 
the storage organ of the plant [22, 25].  This contrasts with starch- and sucrose-storing plants, 
where the amount stored is 5 to 10-fold less [24].   
Fructans are important for the survival of plants, especially under conditions of drought 
and cold temperatures [24, 27-28].   In addition to being a nutrition source when food production 
is limited, fructans may act as a cryoprotectant during cold temperatures, allowing the plant to 
survive osmotic- induced stress [24, 27-28].  When plants are genetically modified to produce 
fructans, the plants show increased survival during drought [27].   Fructan content in C3 grasses 
tends to be highest at the end of the day, and lowest in the morning, consistent with utilization of 
fructans during the night [29].  In the spring, activation of -fructofruranosidase (fructan 
hydrolases) allows the degradation of fructans to fructose which then becomes an important 
nutrition source [25].   
Fructans are present in approximately 15% of flowering plants (approximately 45,000 
plants) [25, 27, 30].  The primary plants producing fructans are in the Gramineae family 
(grasses), which produces primarily inulins,  and the Compositae  family (aster and daisy 
family), which  preferentially produces  levans [26].  Examples of fructan-containing  plants 
include wheat and barley (Poacea family),  onions and tulips (Liliacea family) and the Jerusalem 
chicory and artichoke (Asteraceae family) .  Production of fructans by fructan producing species 7 
 
occurs in both early spring and winter [24].  Nevertheless, total fructan content in C3 grasses 
tends to be highest in the spring, followed by the fall and summer [22].  Fructan production is 
greatest when  photosynthesis is high but  growth is limited such as when there  is a drought or 
cold temperatures  (<12 C°)[27].  Fructan content in underground storage organs such as tubers 
of perennial plants appears to be maximal at the end of the growing season,  and likely help keep 
the plant alive under conditions of low rainfall and seasonality [25, 30]. 
From an evolutionary standpoint,  plant species producing fructans  increased 
approximately 30 to 15 million years ago (Ma) in association with climatological changes  
associated with seasonal drought and cooling [24, 28].  The expansion of fructan-producing 
Gramineae and Compositae families  increased primarily during the early to mid Miocene [28].  
The greatest expansion of fructan producing species occurred in latitudes of 20-60 such as in 
Europe [28]. The period of 15 to 5 Ma is also known for a continued  increased in seasonality 
with global cooling and droughts, in which as  many as  30% of mammalian species became 
extinct [31].  Thus, the ability of mammalian species to harness fructans as a food source could 
have been critical for survival of species during this period. 
 
The Metabolism of Fructans to Fructose by Gut Bacteria 
Fructans can be degraded by fructanases (inulinases and levanases) to generate fructose 
[26, 32-33].   These enzymes are quite effective at generating  fructose; indeed, inulinases 
convert almost all (95%) of inulin to D-fructose in a single step process [32].  However, 
mammals do not produce fructanases, and hence fructans are considered indigestible 
polysaccharides. In contrast, fructanases are produced by some plants, fungi, yeast and bacteria 
[32, 34].  The primary bacteria producing  fructanases are in the Firmicute phyla, and consist 
primarily of gram positive bacteria including  Streptococcus salivarus, Strep mutans, Bacillus sp, 
Clostridia sp, Bifidobacterium, and others [32]. Some Pseudomonas [32]  and Bacteroides 
fragilis [33] may also  produce fructanases. 
  Interestingly, many of the bacteria that degrade fructans  also produce fructans and use 
them for food storage, similar to plants.  One of the best examples is Streptocococcus mutans.  8 
 
Strep mutans lives in the human mouth where it uses sucrose as a major food source, and 
converts it to fructans that are stored in the dental plaque [35-36].  These bacteria then use 
fructanases (such as fructanase A, or fruA) to release the fructans as a food source during the 
time when humans are not eating and hence food is not available. This process turns out to be 
critical for caries formation [35-36].  Interestingly, exposure of these bacteria to fructans or 
sucrose results in the increased expression of fructanase A, whereas glucose represses the 
expression [37].  Studies in broiler chickens have also shown that fructans stimulate the growth 
of fructanase-producing bacteria in the gut, such as Lactobacillus and Bifidobacteria [38].  Thus 
the bacterial flora is highly responsive to diet, and the ingestion of fructans will alter the gut flora 
favoring the growth of fructanase-expressing bacteria. 
Studies of bacterial flora in multiple species have documented that the largest numbers of 
bacteria are in the large intestine, but bacteria are also present in the ileum and to a lesser degree 
in the proximal small intestine [39].    The horse is distinct in having large numbers of anaerobic 
bacteria in the small intestine (which amounts to 70 feet in length), with equal numbers of 
bacteria in both the small and large intestine [40].  When fructans (such as from Jersualem 
artichokes) are administered to horses, there is the rapid degradation of fructans in the small 
bowel [41].  Thus, the administration of fructans is expected to result in fructose generation in 
the gut of horses that have fructan-degrading bacteria.   Consistent with this proposal, we have 
found that fructose levels increase in the blood of some horses eating fructan-rich pasture grasses 
(Figure 4). 
 
Fructans and Bacteria as a General Mechanism for Obesity 
  Recent studies suggest that fructan-degrading bacteria may have a role in obesity. Jeffrey 
Gordon and colleagues demonstrated that obese humans and laboratory animals have a typical 
gut flora consisting primarily of Firmicutes as opposed to Bacteroidetes [42-43].  Firmicutes are 
the primary bacterial phyla producing fructanases [32],  and consistent with this observation, the 
bacteria associated with human obesity were found to have a unique ability to metabolize 
indigestible polysachharides [44] (such as fructans) and to express fructose metabolic activity 
[45] Evidence that these bacteria contribute to obesity was shown by experiments in which the 9 
 
colonic bacteria from obese (ob/ob) mice were transferred to lean mice which resulted in the 
latter gaining more fat as determined by dual-energy X-ray absorptiometry.[45].  Moreover, if 
western diet is given to mice lacking gut bacteria (germ-free mice), obesity does not develop 
[46]. 
 
Antibiotics and Obesity 
Alteration of gut flora by antibiotics has been shown to enhance growth of livestock, and 
especially chickens.  The introduction of antibiotics in animal feed in the 1950s resulted in 
increased “broiler performance”, as noted by a 50% increase in average market weight of 
chickens between 1955 and 1995 [47].  The increase in weight has also been associated with a 
progressive increase in fat content, with a doubling in fat since 1970 [48].  According to some 
estimates, between 3 and 25 million pounds of growth-promoting antibiotics are used each year 
in the USA, which accounts for 13 to 70% of all antibiotic use [47].  This has resulted in 
increased numbers of antibiotic-resistant bacteria with potential public health consequences [39, 
49].  
The mechanism by which antibiotics promote growth and fat content is due to the effects 
of the antibiotics on gut flora.  It is known, for example, that oral antibiotics do not promote 
growth in germ-free chickens [50-51].  Furthermore, the effects of antibiotics on fat content in 
chickens varies.  Some antibiotics, such as penicillin, reduce fat, whereas others, such as 
streptomycin, increase abdominal fat in broilers [52].  This is interesting as penicillin is effective 
against fructanase-expressing Streptococci whereas streptomycin primarily acts on gram 
negative organisms that do not express fructanases. 
While fructanase-expressing bacteria may have a role in driving obesity, a paradox is that 
some studies have reported that the administration of fructans or fructanase expressing bacteria 
may have beneficial effects on obesity.  Both probiotics and prebiotics are now commonly used 
to stimulate growth of chickens and livestock.  Probiotics  are living organisms such as Bacillus 
subtilis and have been reported to reduce abdominal fat [53]. Bacillus subtilis produces 
fructanase.  Some prebiotics are fructans, and have been reported to stimulate good bacteria 
growth, such as Lactobacillus, and are thought to aid weight loss [54-55].  In chickens fructans 10 
 
are thought to increase growth but reduce fat production [56].   Furthermore, short chain fructo-
oligosaccharides (45 g/d for 6 weeks) actually improve insulin sensitivity  in obese  horses 
compared to horses fed the same amount of maltodextrin [57].   Fructans may also reduce serum 
lipids [58] and weight [59] in humans, although most trials were short and often the placebo 
group consisted of sucrose [58].   
The reason for the paradox remains unclear.  We postulate that if the amount of fructan is  
large or prolonged,  virulent fructanase-producing Streptococci could generate sufficient fructose 
that induce a marked inflammatory response in the bowel.  In contrast, the administration of 
lower doses of fructans might not generate the required amount of fructose to cause ATP 
depletion within the intestinal epithelial cells, and hence may act more like fiber that inhibits 
intestinal absorption of sterols and lipids [54].   
 
Relevance to Equine Research 
One of the more serious diseases in horses is laminitis, in which the epidermal lamellae 
of the inner hoof separate from the dermal lamellae of the distal phalanx resulting in lameness 
[22, 60-61].   The laminitis is thought to be initiated by the ingestion of grasses rich in fructans. 
[60-61]  The typical horse may ingest as much as 10-15 kg of pasture grass per day[62],  
resulting in a wide range of fructan ingestion from as little as 0.75 kg to as much as 7 kg [22].   
Thus, a 500 kg horse could ingest as much as 10 to 15 g fructan/kg body wt per day if the grasses 
were rich in fructans [60].  In addition, pasture grasses also contain simple sugars (sucrose, 
fructose and glucose) that can vary from 0.2 to 2.7 kg per day [22].   
Evidence that grasses rich in fructans may have a role in laminitis has been supported by 
experimental studies in which laminitis can be induced within 48 hours by the administration of 
oligofructose (10 g/kg body wt).  The fructans are thought to cause laminitis due to their 
degradation  in the cecum by gram positive bacteria, resulting in the development of lactic 
acidosis and endotoxemia that activates local metalloproteinases that break down the basement 
membrane, causing a detachment of the distal phalanx from the inner hoof wall [60, 63-64].   
Fecal flora is altered following administration of oligofructans, with a shift to gram positive 11 
 
organisms, especially Streptococci [65].  Horses with spontaneous laminitis also show a 
predominance of Streptococcus bovis/equines in the cecum [66].   
 
 
Laminitis is also associated with and predicted by the presence of equine metabolic 
syndrome. [67-69].   The latter is characterized primarily by the presence of insulin resistance, 
often with hypertriglyceridemia, hypertension, and obesity (with preferential fat deposition in the 
neck and tailhead) [67, 70-71].    
While admittedly speculative, it is possible that the chronic ingestion of fructans may 
induce the expression of fructanase-producing Streptococci, and that the sudden ingestion of a 
massive amount of fructans can lead to the rapid generation of fructose in the small intestine and 
hindgut.  Some of the fructose generated would be metabolized in the intestinal wall leading to 
local inflammation with increased intestinal permeability and endotoxemia, some fructose might 
enter the liver to stimulate insulin resistance, and the rest would be degraded by local bacteria 
resulting in a local acidosis.  We recommend studies examining the expression and activity of 
fructokinase in equine metabolic syndrome and laminitis. 
  In conclusion, the  preferential expression of fructans in temperate  grasses appears to 
have had  evolutionary benefit for the  plants to survive under  drought or colder  temperatures, 
but  may have also  provided  a survival  pathway for mammals in  which  intestinal and colonic  
fructanase-expressing  bacteria were present.  However, in the setting where excessive amounts 
of fructans are ingested, it may provide a stealth source of fructose that could be playing a role in 
both equine associated metabolic syndrome and laminitis. 12 
 
  
Figure 1  Metabolism of Fructose.  Fructose enters intestinal epithelial cells via the Glut5 
transporter, and is then metabolized by fructokinase C, resulting in the generation of fructose-1-
phosphate that is further metabolized to generate glucose, glycogen and triglycerides.  During the 
initial phosphorylation of fructose, ATP depletion commonly occurs, resulting in the turnover of 
adenine nucleotides with the generation of uric acid,  oxidants, and inflammatory mediators 
(such as chemokines). 
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Figure 2.  Fructokinase C is expressed throughout the intestines in mice.  Four-month-old 
male wild type mice (WT) or fructokinase A/C knockout mice (KHK-A/C KO), which were 
C57BL6 background, were sacrificed after 20 hours of fasting and the intestines (duodenum, 
jejunum, cecum and colon) removed and the lining scraped, and analyzed for fructokinase C 
(KHK-C) mRNA expression by quantitative real time PCR using -actin as an internal control.  
Fructokinase C is expressed in both the small and large bowel in the wild type mouse. N = 3-4 
per group.  All data are presented as the mean ± s.e.m.   
 14 
 
 
Figure 3  Fructokinase mediates intestinal permeability in mice. Three-month-old male wild 
type (WT) mice or fructokinase A/C knockout mice (KHK-A/C KO) (obtained from David 
Bonthron, Leeds , UK)[72] were administered fructose with normal chow for 3 weeks.   Two 
additional groups of WT mice and KHK-A/C KO mice were given normal chow with tap water 
that did not contain fructose as a control.  Due to the different preference for fructose water 
between WT mice and KHK-A/C KO mice, mice were given 15% or 30% of fructose water, 
respectively.  Both WT mice and KHK-A/C KO mice drank the same amount of fructose (Figure 
A).  For each group, the duodenum was removed after 20 hours of fasting of normal chow and 
the lining scraped and RNA extracted.  Quantitative real time PCR was performed for 
fructokinase C (KHK-C, Figure B), and tight junction genes occludin (Figure C) and ZO-1 
(Figure D) using  actin as an internal control. As shown, WT mice fed fructose show an 
upregulation of KHK mRNA expression in association with a significant decrease in occludin 
and ZO-1 mRNA.  These studies suggest fructose is increasing intestinal permeability.  The 
observation that this does not occur in fructokinase KO mice suggests that the intestinal 
permeability is mediated by fructokinase.  N = 3-4 per group.  All data are presented as the mean 
± s.e.m.  Data graphics and statistical analysis was performed using Prism 5 (GraphPad).  Data 
was analyzed by one-way ANOVA with the Tukey post hoc test.  P < 0.05 was regarded as 
statistically significant.  N.S., not significant.   15 
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Figure 4   Serum Fructose levels increase in a Horse eating Pasture-rich Fructans.  In a 
study performed in 2005 in a horse pasture in Virginia, serial blood samples were taken from 
horses throughout the day (provide by the Equine Studies Group, Waltham Centre for Pet 
Nutrition, UK Equine).  Fructan content of the pastural grasses showed a peak level in April, 
with concentrations of fructose reaching 5-6% of the dry weight by the end of the day.  This is 
significantly less than what has been reported in some studies (in which fructans can increase to 
40-50% content of grasses) [60]. Nevertheless, in some horses a rise in serum fructose could be 
observed at the end of the day, consistent with the hypothesis that some fructans are being 
converted to fructose. 17 
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